APC: On-Demand Webinars

APC Education

On-demand education

We know you’re not always able to take a continuing education course at a specific time and date. That’s why APC also offers our live courses on-demand. Although you can’t ask questions in real time, you get the same CE credit, and you can take the class anytime, anywhere, and review the video as often as you like.

On-demand versions of our live courses usually become available about a week after the live presentation.

Survey of State Compounding Law Changes – 2022 and Proposed 2023

Speaker: David A. Kosar, Esq.

Federal policy affects your compounding practice; however, not nearly as much as state laws and regulations do. Pharmacy standards and requirements are guided by regulations and laws in every state, with every jurisdiction also playing a role, including expiration dates for products, requirements for secure storage, recordkeeping, and more.

Compounding laws and regulations in states across the US saw the adoption of some significant changes during 2022—so, what does 2023 hold?

This activity aims to re-cap 2022 adopted changes in compounding laws and regulations across the US and highlight proposed changes currently in the 2023 sessions.

Click here to register

Pharmacy Finance 101: A Guide to Key Financial Elements to Facilitate the Success of Your Pharmacy

Speaker: Scotty W. Sykes, CPA, CGMA

Pharmacy practice has evolved into a dual role of a provider of healthcare as well as a business to ensure longevity for continual patient care while maintaining profitable outcomes. Understanding your financial information is, therefore, a key fundamental pillar of a successful pharmacy.

This webinar will discuss the key aspects of pharmacy accounting, financial statements, and key performance indicators that you need to know to maximize your bottom line and understand your pharmacy. This webinar will also touch on key tax strategies that you need to consider to help minimize your tax liability and improve your cash flow.

click here to register

How to Use Medical Literature to Identify and Support Compounded Therapies

Speaker: Nat Jones, RPh, FAPC

In a world of one-offs how do you develop a compounded treatment formula? It is essential to start with knowledge of the disease state, understanding the biology & pathophysiology involved and what are the pharmacologic therapeutic targets or goals.

The best place to obtain the most current knowledge on these topics is medical literature in both journal and text publications. The internet has brought the explosion of world’s scientific literature to our fingertips, but how do you decide what is fact from fiction or just bad science?

Click here to register

Research and Development Tax Credit

Speakers: Heather Fisher, Business Development Manager, Software & Pharmaceuticals and Dawson Fercho, Partner and VP of Business Development, CTA, Inc.

Does your compounding pharmacy qualify for tax credits? What tax incentives can be applied to your pharmacy? These questions if overlooked or not fully investigated, may hinder pharmacies taking full advantage of tax credits/incentives.

While Research & Development (R&D) incentive programs exist for compounding pharmacies, many pharmacies are not familiar with the extent to which they can benefit from R&D incentives. Recent laws surrounding the Employee Retention Credit (ERC) may also provide further tax incentive opportunities.

This webinar explores tax incentives for the compounding pharmacy, with a focus on the R&D tax credit and ERC and real-life case studies as examples. Whether you are a well-established pharmacy or just starting up, this activity is a must-see to help guide you to reduce your taxes, save, and grow.

Click here to register

Can You Compound That? A Quiz Show

Tenille Davis, PharmD, RPh, BCSCP, FACP

In addition to ensuring whether the compounded prescription is appropriate for the particular patient, determining whether the preparation itself can be compounded is part of the daily decision-making process faced by compounding pharmacists and pharmacy technicians.

Set in a game show style format, this fun and interactive webinar aims to enhance your knowledge on which active ingredients can (and can’t) be compounded, as well as guidance on general recommendations on facilitating decisions on whether to compound a preparation.

Click here to register

Keeping it Legit: Best Authentication Practices for Compounders, PART II – WHOLESALE DISTRIBUTORS

Denise Frank, RPh, FACA, FAPC

This activity aims to uncover how pharmacists can identify the potential sale of counterfeit, stolen, contaminated, or harmful drug products from wholesale distributors, and what do in these situations.

The program will explore the regulations set forth by the Drug Supply Chain Security Act (DSCSA) that protects drug product integrity and security; risky situations; diversion of products outside the supply chain (i.e., can you sell products to a wholesaler?); counterfeits/adulteration/misbranding; maintaining product integrity; how to authenticate suppliers (initial and ongoing); red flags, and more.

click here to register

Keeping it Legit: Best Authentication Practices for Compounders, PART I – PROVIDERS AND PRESCRIPTIONS

Kathy A. Salinas, PharmD

This program aims to describe optimal approaches to validating legitimate prescriptions by exploring interactions with the prescriber such as verifying a valid doctor–patient relationship, prescriptions that are within their scope of practice, treatments that are individualized, among others. This activity will also explore controlled substance prescriptions, with a focus on a “Red Flags” Checklist for pharmacies to facilitate professional judgment on the legitimacy of such a prescription.

CLICK HERE TO REGISTER

Hazardous Drug Decontamination – Understanding its Purpose and Validating Best Practices

Abby Roth

This activity aims to clarify the purpose of decontamination of non-sterile and sterile preparations by exploring the differences between deactivation, decontamination, cleaning, and disinfection, as well as discussing appropriate agents for the decontamination of HD on surfaces. Under a practice setting, the program will also explore the importance of verifying processes and agents for decontaminating, while discussing procedures for validating effective HD decontamination.

Click here to register

20 Questions: Selecting the Right Compounding Software for Your Practice

Alexander Pytlarz, PharmD

This program will explore the different facets of compounding pharmacy management (e.g., inventory management, compliance, master formulations) through a series of 20 compounding management-specific questions that will help facilitate the decision-making process when you are selecting the best compounding software for your practice.

Click here to register

503A Compounding for Shortages

Shawn Hodges, PharmD; Kathleen Kane, PharmD, BCSCP, DPLA; Karla Palmer, Esq.

This program will focus on recent involvement with Federal, State, County, and 503B stakeholders, as well as with drug shortage lists and the impact of the FDA’s temporary guidance during the COVID-19 pandemic to illustrate the extent to which 503A pharmacies can help patients receive the medications they need.

Click here to register

Compounded Thyroid: How to Start the Conversation With Your Provider

Michelle Moser, RPh

Commercial thyroid products simply don’t work for every patient. Whether it’s dosage limits, allergies, or other issues, you’re going to have to explain to prescribers why compounded thyroid is often the best option for a patient.

Learn to educate them (and your patients), and pick up some important best practices for working with thyroid options.

Click here to register

BUDs & Stability Studies Under the Proposed New USP Chapters

Mindy Cormier, PharmD, R.Ph.

Beyond-use dates have become a hot topic for compounding pharmacists. This session will review the discussion surrounding non-sterile and sterile beyond-use date appeals, and the importance of beyond-use dating for facilitating workflow efficiencies and patient access to personalized medicine. New requirements for default and extended beyond-use dating according to proposed USP <795> and <797> will be included, as well as what to look for in a stability-indicating study. Attendees will learn how to apply professional judgment in extrapolating stability data for extending beyond-use date.

CPE was originally part of EduCon 2022.

Click here to register

USP: Minor Chapters, Major Impacts

Brian Kelley

In this session, our speaker will outline regulatory considerations for USP Chapters and FDA guidelines, and explain USP <61> and USP <62> tests and how they determine if non-sterile products meet quality requirements. The significance of USP <51> preservative-effectiveness testing in compounding, the importance of a container closure system for a drug product, and the test requirements for compounded preparations in USP <1163> will be detailed as well.

CPE was originally part of EduCon 2022.

Click here to register

The Biopharmaceutical Classification System: What You Should Know

Vanessa Pinheiro, Pharmacist Consultant

This session will look at the classes of the Biopharmaceutical Classification System (BCS) and the importance of drug dissolution for absorption after oral administration of solid dosage forms. Excipients that could impact the dissolution of active pharmaceutical ingredients (APIs), considerations for formulation development when compounding from an API or an existing drug product, and literature related to the BCS and compounding pharmacy will be included.

CPE was originally part of EduCon 2022.

Click here to register

USP <797> BUDs: An Update

Connie Sullivan

USP Chapters have recently undergone several changes, including standards for beyond-use dates. Our speaker will review USP’s process for standard creation, summarize the revisions proposed for USP <797> and discuss the next steps for the chapters. Attendees will learn where to find the proposed revisions to the chapters and the supplementary materials.

CPE was originally part of EduCon 2022.

Click here to register

USP <795> BUDs: An Update

Gus Bassani, PharmD

USP Chapters have undergone much change in recent year, including standards for beyond-use dates. Our speaker will review USP’s process for standard creation, summarize the revisions proposed for USP <795> and discuss the next steps for the chapters. Attendees will be provided with information on where to find the proposed revisions to the chapters and the supplementary materials.

CPE was originally part of EduCon 2022.

Click here to register

Implementing Pharmacogenomic Testing in Your Practice

Peter Clapp, Ph.D. and Lisa Faast, PharmD

Adding pharmacogenomic testing to your pharmacy practice can increase revenues and improve patient outcomes. This session will include a review of single nucleotide polymorphisms (SNPs) in pharmacogenetic analyses and the possible consequences of metabolic enzyme polymorphism on drug disposition. You will learn how to identify potential patients for PGx testing, recognize compensation models for PGx services, and how to market this service to grow your pharmacy.

CPE was originally part of EduCon 2022.

Click here to register

R&D Roundtable: How Compounders are Aiding Medical Research

Facilitator: Alexander Pytlarz, R.Ph.; Panelists: Linda McElhiney, R.Ph.; Joe Navarra, R.Ph.; and David Mastropietro, R.Ph., Ph.D.

There is a wide range of medical research projects in which compounders are engaged and can be engaged. Our panel of speakers will provide attendees with an understanding of the research protocols under which compounders can engage in supporting medical research projects and explain how to cultivate relationships with medical research and identify R&D opportunities related to compounding.

CPE was originally part of EduCon 2022.

Click here to register

Cultural Competency & Bias Training

Denise Frank, BPharm, R.Ph., FACA

The Affordable Care Act’s Section 1557, “Nondiscrimination in Health Programs and Activities,” was created to reduce disparities in health care and prohibits discrimination on the basis of sex in federally funded health programs. This session will provide examples of discrimination, and review key provisions of the rule, including enforcement and consequences of noncompliance. Attendees will learn how to recognize types of discrimination and develop a plan for their work setting to become compliant.

CPE was originally part of EduCon 2022.

Click here to register

Compounder Ethics: The Code as Compliance Strategy

Barbara Exum

This session will review the new code of ethics adopted by Alliance for Pharmacy Compounding, The Pharmacy Compounding Professional’s Code of Ethics. Characteristics of ethical behavior in the practice of pharmacy and ethical principles as they relate to compounders will be included. Our speaker will also describe frameworks used in ethical decision-making that you can use when confronted with ethical dilemmas.

CPE was originally part of EduCon 2022.

Click here to register

Veterinary Compounding: Considerations & Clinical Pearls

Deborah Clark, R.Ph.

Compounding for veterinary patients requires special considerations when choosing a route of administration and dosage form for a given species. Our speaker will provide an overview of toxicities to consider when choosing a commercially available drug product or when formulating a compounded product, as well as appropriate dosage forms for the canine, feline and equine patient. Unique dosage form options that may give a better therapeutic outcome in certain species will be included.

CPE was originally part of EduCon 2022.

Click here to register

When the DEA Comes Calling: Preparing for and Managing that Inspection

Larry Houck

What do you do when the Drug Enforcement Administration (DEA) inspector shows up at your pharmacy? What is the extent of DEA inspection authority and what enforcement actions can occur? This session will help you prepare for and know what to expect during a DEA inspection, including do’s and don’ts, policies and procedures, and the importance of conducting a post-inspection mirror audit.

CPE was originally part of EduCon 2022.

Click here to register

Neuroinflammatory disorders

Jim Hrncir and Ashley Berthelot

Explore innovative protocols and opportunities to optimize outcomes for patients suffering from debilitating neuroinflammatory disorders. Paired well with discussions on provider outreach tactics and how to best educate providers on the clinical mechanisms behind these protocols — this program will open the doors to new possibilities.

Click here to register

Controlled Substances & the Corresponding Responsibility of the Pharmacist and Pharmacy Technician

With Erika Fallon, PharmD, RPh

The DEA’s recently revised “Pharmacist Manual” states, “To be valid, a prescription for a controlled substance must be issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice. The practitioner is responsible for the proper prescribing and dispensing of controlled substances, but a corresponding responsibility rests with the pharmacist who fills the prescription.”

Compounding pharmacists may find themselves uniquely vulnerable to enforcement action and penalties provided for violations of the provisions of law relating to controlled substances. 21 U.S.C. 841(a)(1) and 21 CFR 1306.04(a). Specific challenges include “off-label” usage of controlled substances, novel therapies that are not well established in scientific literature, and unreliable information regarding what other medications patients are taking. This program seeks to educate and equip pharmacists and pharmacy technicians on best practices and strategies to ensure compliance, including recognizing red flags, patients with substance abuse disorders, over-utilization, documentation of diagnosis, and checking the Prescription Drug Monitoring Program (PDMP).

Click here to register

Some Hot Topics Concerning Hazardous Drugs

With L. Rad Dillon, RPh

Despite being available for review for a number of years, confusion and misunderstandings remain concerning USP <800>, especially regarding certain key topics. This presentation will examine two such topics, personal protective equipment and cleaning & disinfection, in a manner that makes the requirements understandable and easy to apply. Material will be organized in an easy-to-understand fashion, making use of tables, charts, and key takeaways. With the official implementation of proposed USP <795> and <797>, as early as a few months away, inspection-ready compliance with USP <800> will be required for all States governed by USP standards, if not already required.

Click here to register

HVAC and Cleanroom Workflow

With Bryan Prince, MBA

One of the most important criteria for the success of a compliant sterile and/or nonsterile compounding room is the HVAC system. USP and ISO have minimum particle count classifications, as well as air changes per hour requirements which are foundational to certifying a cleanroom. Additionally, people and process generate heat and seasons change, all of which affect the performance for the HVAC system connected to the cleanroom. During this presentation, we will clearly define how to design an appropriate HVAC system, taking into account compounding workflow considerations.

Click here to register

Surviving an Inspection

With Melissa Stefko, MBA

In this activity, we will discuss how to prepare for and what to expect during an inspection. We will cover firm’s rights during an inspection, common inspection techniques used by auditors and appropriate responses. Additionally we will go through common items investigated as well as common investigational findings in compounding pharmacies. Lastly, we will also cover how to write an effective response to the regulatory agency.

Click here to register

 


 

Even more courses

Through partnerships with LP3 and SeminarWeb, APC offers additional on-demand continuing education classes related to pharmacy compounding from APC and other publishers.

CLICK HERE TO SEE THE LP3 NETWORK CATALOG

Click here to see the SeminarWeb catalog